Overview
Neonatal giant cell hepatitis is a rare liver disorder characterized by the presence of multinucleated giant cells in the liver parenchyma, often associated with hemorrhagic tendencies leading to complications such as intracranial hemorrhage 1.Diagnosis
Clinical Presentation: Sudden unexpected death, particularly with a history of intracranial hemorrhage 1.
Histopathology: Identification of multinucleated giant cells in liver biopsy or autopsy samples 1.
Imaging: May reveal signs of intracranial hemorrhage or other complications 1.
Laboratory Tests: Elevated liver enzymes, coagulation abnormalities, and potentially abnormal bilirubin levels 1.Management
Supportive Care: Focus on managing intracranial hemorrhage and other complications 1.
Monitoring: Close monitoring of coagulation parameters and neurological status 1.
Liver Support: In severe cases, consider liver transplantation, though specific protocols are not detailed in the provided abstracts 1.Special Populations
Neonates: Condition primarily affects neonates, with cases presenting between 37 to 52 days of age 1.Key Recommendations
Autopsy Evaluation: Perform thorough autopsy evaluations in cases of sudden unexpected death in neonates to rule out neonatal giant cell hepatitis 1 (Evidence: Weak).
Monitor Hemorrhagic Tendencies: Closely monitor for and manage hemorrhagic tendencies, especially intracranial hemorrhage, in neonates suspected of having neonatal giant cell hepatitis 1 (Evidence: Weak).
Consider Liver Transplantation: Evaluate the need for liver transplantation in severe cases with multi-organ involvement, though specific criteria are not provided 1 (Evidence: Expert opinion).References
1 Sugai M, Kono R, Hiroki T, Kunita Y, Tokudome S. Four autopsy cases of neonatal giant cell hepatitis died suddenly and unexpectedly from intracranial hemorrhage. Acta pathologica japonica 1978. link